TUMOR LYSIS SYNDROME IN PEDIATRIC ALL: PREVENTION GAP AND DERIVATION OF THE LISIS SCORE IN A LOW-RESOURCE SETTING (SIOP 2026) - Oct 23, 2026 - Abstract #Shift 02 - 020; Pres time: Sep 17, 2026; Location: Exhibition Area; "TLS affects 1 in 10 pediatric ALL patients in our LMIC setting, with profound impact on survival and ICU utilization. Only 1 in 5 patients who developed TLS had prior prophylaxis — a critical prevention gap. The LISIS Score would enable systematic bedside risk stratification (available at: www.cancernet.mx/slt) without advanced testing, potentially optimizing hyperhydration and allopurinol use where rasburicase is unavailable."
Clinical • Acute Lymphocytic Leukemia • Oncology • Pediatrics
|
|
Ingrid Amalinalli Ortiz Reyes; Oscar Ramirez Cardenas; Lilia Edith Carrizales Torres; Liliana Velasco Hidalgo; Cesar Galvan
|